Cargando…
p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function
The p16/RB1 tumor suppressor pathway is inactivated in the vast majority, if not all, human cancers. The current paradigm is that p16 and RB1 function in a linear pathway to suppress tumorigenesis; however p16 is preferentially lost in human cancers suggesting that p16 has critical tumor suppressive...
Autores principales: | Sen, M, Akeno, N, Reece, A, Miller, A L, Simpson, D S, Wikenheiser-Brokamp, K A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520502/ https://www.ncbi.nlm.nih.gov/pubmed/28414317 http://dx.doi.org/10.1038/oncsis.2017.5 |
Ejemplares similares
-
p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
por: Akeno, Nagako, et al.
Publicado: (2014) -
RB depletion is required for the continuous growth of tumors initiated by loss of RB
por: Doan, Alex, et al.
Publicado: (2021) -
Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture
por: Hoskins, Elizabeth E., et al.
Publicado: (2008) -
Inhibition of pituitary tumors in Rb mutant chimeras through E2f4-loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis
por: Parisi, Tiziana, et al.
Publicado: (2008) -
Requirement for phosphorylation of P53 at Ser312 in suppression of chemical carcinogenesis
por: Slee, Elizabeth A., et al.
Publicado: (2013)